These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors that determine the in vivo dose-response relationship for stable chromosome aberrations in A-bomb survivors. Awa AA, Nakano M, Ohtaki K, Kodama Y, Lucas J, Gray J. J Radiat Res; 1992 Mar; 33 Suppl():206-14. PubMed ID: 1507170 [Abstract] [Full Text] [Related]
4. Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH. Kodama Y, Nakamura N, Nakano M, Ohtaki K, Hamasaki K, Noda A. Int J Radiat Biol; 2024 Mar; 100(8):1155-1164. PubMed ID: 38991111 [Abstract] [Full Text] [Related]
6. G-banding analysis of radiation-induced chromosome damage in lymphocytes of Hiroshima A-bomb survivors. Ohtaki K. Jpn J Hum Genet; 1992 Dec; 37(4):245-62. PubMed ID: 1297446 [Abstract] [Full Text] [Related]
7. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb. Brenner DJ. Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511 [Abstract] [Full Text] [Related]
8. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons. Sasaki MS, Endo S, Ejima Y, Saito I, Okamura K, Oka Y, Hoshi M. Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767 [Abstract] [Full Text] [Related]
9. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system. Otake M, Schull WJ. Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666 [Abstract] [Full Text] [Related]
10. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation. Kodama Y, Pawel D, Nakamura N, Preston D, Honda T, Itoh M, Nakano M, Ohtaki K, Funamoto S, Awa AA. Radiat Res; 2001 Oct; 156(4):337-46. PubMed ID: 11554845 [Abstract] [Full Text] [Related]
11. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki. Kerr GD, Egbert SD, Al-Nabulsi I, Bailiff IK, Beck HL, Belukha IG, Cockayne JE, Cullings HM, Eckerman KF, Granovskaya E, Grant EJ, Hoshi M, Kaul DC, Kryuchkov V, Mannis D, Ohtaki M, Otani K, Shinkarev S, Simon SL, Spriggs GD, Stepanenko VF, Stricklin D, Weiss JF, Weitz RL, Woda C, Worthington PR, Yamamoto K, Young RW. Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626 [Abstract] [Full Text] [Related]
12. New dosimetry of atomic bomb radiations. Fry RJ, Sinclair WK. Lancet; 1987 Oct 10; 2(8563):845-8. PubMed ID: 2889042 [Abstract] [Full Text] [Related]
14. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review. Sasaki MS, Endo S, Hoshi M, Nomura T. J Radiat Res; 2016 Nov 10; 57(6):583-595. PubMed ID: 27614201 [Abstract] [Full Text] [Related]
15. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima. Kodama Y, Ohtaki K, Awa AA, Nakano M, Itoh M, Nakamura N. Radiat Res; 1999 Nov 10; 152(5):558-62. PubMed ID: 10521934 [Abstract] [Full Text] [Related]
18. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory. Rühm W, Carroll KL, Egbert SD, Faestermann T, Knie K, Korschinek G, Martinelli RE, Marchetti AA, McAninch JE, Rugel G, Straume T, Wallner A, Wallner C, Fujita S, Hasai H, Hoshi M, Shizuma K. Radiat Environ Biophys; 2007 Nov 10; 46(4):327-38. PubMed ID: 17828415 [Abstract] [Full Text] [Related]
20. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Chromosome abnormality in early entrants. Kamada N. J Radiat Res; 1991 Mar 10; 32 Suppl():275-7. PubMed ID: 1762115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]